Table 1.
PH group 2 | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Comparator group |
---|---|---|---|---|---|---|
Patient count by continent | ||||||
America | 1935 (58%) | 509 (15%) | 538 (16%) | 184 (5%) | 185 (6%) | 506 |
Europe | 3948 (38%) | 2491 (24%) | 1849 (18%) | 1913 (18%) | 272 (3%) | 1229 |
Total | 5883 (43%) | 3000 (22%) | 2387 (17%) | 2097 (15%) | 457 (3%) | 1735 |
Age at diagnosis | ||||||
0–9 | 40 | 2 | 0 | 0 | 0 | 0 |
10–19 | 130 | 1 | 7 | 5 | 1 | 3 |
20–29 | 361 | 11 | 18 | 47 | 11 | 57 |
30–39 | 616 | 46 | 60 | 123 | 32 | 117 |
40–49 | 967 | 128 | 197 | 244 | 72 | 235 |
50–59 | 1120 | 353 | 435 | 364 | 123 | 363 |
60–69 | 1297 | 731 | 785 | 535 | 120 | 446 |
70–79 | 1077 | 1238 | 732 | 565 | 77 | 421 |
80–89 | 272 | 477 | 151 | 211 | 21 | 92 |
90–99 | 3 | 13 | 2 | 3 | 0 | 1 |
Note: 218 patients (1.6%) had more than one PH group assigned, and 447 patients (3.2%) were not yet definitively assigned to any group.
Abbreviation: PH, pulmonary hypertension.